Posted in | News | Petrochemicals

Shell Announce Successful First Turnaround at Chinese Ethylene Cracker

Shell Chemicals announced the successful first turnaround at the CSPCL - "Nanhai" petrochemicals joint venture complex in Guangdong, China. Nanhai is a joint venture with China National Offshore Oil Company (CNOOC). The turnaround was completed while simultaneously carrying out the debottlenecking of an ethylene cracker and process units. Both were finished ahead of time and within budget.

Debottlenecking the ethylene cracker, ethylene oxide/ethylene glycols, and styrene monomer/propylene oxide process units will improve the site's competiveness by increasing capacity and reducing unit costs. After the debottlenecking, the annual ethylene capacity went from 800 kilotonnes per annum to 950 ktpa, with total petrochemical production capacity at the plant increasing from 2.3 million tonnes to 2.7 million tonnes.

"Executing a turnaround and simultaneous debottlenecking project on this scale, within budget and on time is impressive and highlights the robust working partnership between Shell and CNOOC," said Ben van Beurden, Executive Vice President, Shell Chemicals. "The decision to increase capacity at Nanhai supports the Shell strategy to grow selectively and to continue to remain a leader in the expanding Asian petrochemicals market."

The debottlenecking project included construction of an eighth liquid cracking furnace for light and heavy feedstock. Four out of five derivative plants were debottlenecked by 10% to 30%. The planned turnaround took place in March and April this year. In addition to a broad range of planned maintenance activities, more than 1,000 pressure vessels were opened for statutory inspections. The project also included significant instrumentation work.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.